Denali Therapeutics Inc. (DNLI) Reports Q4 Loss, Misses Revenue Estimates
28/2 23:25
Denali Therapeutics Inc. (DNLI) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to earnings of $1.91 per share a year ago. These figures are adjusted for non-recurring items....